In comparison to BPH, our bioinformatics combined enrichment analysis revealed that key genes EGFR, MYC, VEGFA, and PTEN were identified as potent molecular biomarkers of PCa from gene expression profiling. Here, MYC is linked to benign prostatic hyperplasia.